185 related articles for article (PubMed ID: 14665529)
1. Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy.
Hage CA; Wood KL; Winer-Muram HT; Wilson SJ; Sarosi G; Knox KS
Chest; 2003 Dec; 124(6):2395-7. PubMed ID: 14665529
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous cryptococcosis during infliximab therapy.
Chiriac A; Mares M; Mihaila D; Solovan C; Moldovan C; Stolnicu S; Hagen F
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27637071
[No Abstract] [Full Text] [Related]
3. Disseminated cryptococcal infection and anti-tumor necrosis factor-alpha treatment for refractory sarcoidosis: an expected association?
Arnaud L; Sene D; Costedoat-Chalumeau N; Cacoub P; Chapelon-Abric C; Piette JC
J Rheumatol; 2009 Feb; 36(2):462-3. PubMed ID: 19208587
[No Abstract] [Full Text] [Related]
4. Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel.
Shrestha RK; Stoller JK; Honari G; Procop GW; Gordon SM
Respir Care; 2004 Jun; 49(6):606-8. PubMed ID: 15165294
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab-associated pulmonary cryptococcosis.
Iwata T; Nagano T; Tomita M; Suehiro Y; Nakatsuka S; Kimura H; Sakaki M
Ann Thorac Cardiovasc Surg; 2011; 17(4):390-3. PubMed ID: 21881327
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab.
Wilson ML; Sewell LD; Mowad CM
J Drugs Dermatol; 2008 Jan; 7(1):53-4. PubMed ID: 18246698
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.
Toussirot E; Berthelot JM; Pertuiset E; Bouvard B; Gaudin P; Wendling D; le Noach J; Lohse A; Lecuyer E; Cri L
J Rheumatol; 2009 Nov; 36(11):2421-7. PubMed ID: 19797509
[TBL] [Abstract][Full Text] [Related]
8. Asymptomatic pulmonary cryptococcosis in a patient with Crohn's disease on infliximab: case report.
Hirai F; Matsui T; Ishibashi Y; Higashi D; Futami K; Haraoka S; Iwashita A
Inflamm Bowel Dis; 2011 Jul; 17(7):1637-8. PubMed ID: 21674724
[No Abstract] [Full Text] [Related]
9. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
10. Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis.
Kozic H; Riggs K; Ringpfeil F; Lee JB
J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S95-6. PubMed ID: 18489059
[No Abstract] [Full Text] [Related]
11. [Case of pulmonary cryptococcosis which developed in a patient receiving abatacept therapy for rheumatoid arthritis].
Karino T; Osaki K; Kanamori K; Yahata T
Nihon Kokyuki Gakkai Zasshi; 2010 Dec; 48(12):980-4. PubMed ID: 21226309
[TBL] [Abstract][Full Text] [Related]
12. Pneumonitis caused by Legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab).
Li Gobbi F; Benucci M; Del Rosso A
J Clin Rheumatol; 2005 Apr; 11(2):119-20. PubMed ID: 16357717
[No Abstract] [Full Text] [Related]
13. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Hochman D; Wolff B
JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
[No Abstract] [Full Text] [Related]
14. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Callegari PE; Schaible TF; Boscia JA
JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
[No Abstract] [Full Text] [Related]
15. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Costenbader KH; Glass R; Cui J; Shadick N
JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
[No Abstract] [Full Text] [Related]
16. Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.
Mori S; Imamura F; Kiyofuji C; Sugimoto M
Mod Rheumatol; 2006; 16(4):251-5. PubMed ID: 16906378
[TBL] [Abstract][Full Text] [Related]
17. Cavitating pneumonia after treatment with infliximab and prednisone.
Arend SM; Kuijper EJ; Allaart CF; Muller WH; Van Dissel JT
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):638-41. PubMed ID: 15278730
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal meningitis in an HIV-negative patient with rheumatoid arthritis treated with rituximab.
Wingfield T; Jani M; Krutikov M; Mayer J; Uriel A; Marks J; Ustianowski AP
Rheumatology (Oxford); 2011 Sep; 50(9):1725-7. PubMed ID: 21700684
[No Abstract] [Full Text] [Related]
19. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
Amano K
Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997
[No Abstract] [Full Text] [Related]
[Next] [New Search]
